Duopharma Biotech Berhad (KLSE:DPHARMA)
1.200
-0.030 (-2.44%)
At close: Mar 28, 2025
Duopharma Biotech Berhad Revenue
In the year 2024, Duopharma Biotech Berhad had annual revenue of 813.70M MYR with 15.46% growth. Duopharma Biotech Berhad had revenue of 193.67M in the quarter ending December 31, 2024, with 15.62% growth.
Revenue
813.70M
Revenue Growth
+15.46%
P/S Ratio
1.42
Revenue / Employee
493.15K
Employees
1,650
Market Cap
1.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Malayan Banking Berhad | 27.94B |
Public Bank Berhad | 14.04B |
Tenaga Nasional Berhad | 65.83B |
CIMB Group Holdings Berhad | 20.87B |
IHH Healthcare Berhad | 24.38B |
Press Metal Aluminium Holdings Berhad | 14.91B |
Hong Leong Bank Berhad | 6.19B |
Celcomdigi Berhad | 12.75B |